1. Herceptin ® in the adjuvant setting 2. Herceptin ® in the adjuvant setting: rationale HER2 overexpression is an early event in breast cancer development and is associated…

1. JOURNAL CLUB 13/09/2012 DR. R. RAJKUMAR III YR POST GRADUATEDEPARTMENT OF MEDICAL ONCOLOGY 2. Question 1• Important prognostic factors in breastcancer include:– A.…

1. DISCLAIMER This slide deck in its original and unaltered format is for educational purposes and is current as of September 2012. All materials contained herein reflect…

1.Genomic HealthOncotype DXE25 Project MuthuAlagappanVaishnav Aradhyula2. Pitch OutlineReview of ScienceHuman Genome Project3. Gene Expression and RT-qPCRIntroduction to…

1.Genomic HealthOncotype DXE25 Project MuthuAlagappanVaishnav Aradhyula2. Pitch OutlineReview of ScienceHuman Genome Project3. Gene Expression and RT-qPCRIntroduction to…

SÖZLÜ BİLDİRİLER 1 NOLU SÖZLÜ BİLDİRİ Her2 Signaling Regulates The Mammary Stem/progenitor Cell Population Driving Tumorigenesis And Invasion Hasan Korkaya*, Amanda…

OpenJDK 64-Bit Server VM warning: Insufficient space for shared memory file: 9536 Try using the -Djava.io.tmpdir= option to select an alternate temp location. PowerPoint…

Moving forward: Herceptin® in the adjuvant setting â Trials in which Herceptin® is combined with chemotherapy Elizabeth Tan-Chiu Medical Oversight NSABP Operations…

Slide 11Kitasato-Harvard Symposium 10/03/2002 New Monoclonal Antibody Approved for Advanced Breast Cancer Shin-ichi Nihira, Ph.D. Dept. Clinical Research 3 Chugai Pharmaceutical…

Slide 1 1 1 Review Experience in Evaluating Predictive Biomarkers – Design and Analysis Considerations Yuan-Li Shen, Dr. P.H. U.S. Food and Drug Administration Center for…